Company / R&D per Share
Royalty Pharma plc R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.75
FY2025
5-year range
$0.00 / $0.75
FY2021-FY2025
Trend
+16317.6%
vs FY2024
Sector context
#159 of 208
Health Care
What the data says
R&D per Share changed +16318% YoY in FY2025, a notable deviation from the 5-year average annual change of +3231%.
Based on SEC 10-K filings.
0.75 in FY2025 with a 5-year CAGR of -6.4%.
Improved from $0.13 to $0.75 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +120.4%
- 5-Year CAGR
- -6.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 208This company $0.75 Sector average $12.19
▼
-93.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 16317.6% year-over-year.
- Ranks #159 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.75 | +16317.6% |
| FY2024 | $0.00 | -96.4% |
| FY2023 | $0.13 | +79.0% |
| FY2022 | $0.07 | -68.3% |
| FY2021 | $0.22 | -78.9% |
| FY2020 | $1.05 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026